A Study to Evaluate the Long-Term Safety and Efficacy of Bimekizumab in Subjects With Psoriatic Arthritis

Pa0009 028, Rochester

Pa0009 001, Duncansville

Pa0009 003, Hagerstown

Pa0009 004, Charleston

Pa0009 010, Jackson

Pa0009 025, Lexington

Pa0009 011, Lansing

Pa0009 013, Mesquite

Pa0009 006, Dallas

Pa0009 014, Portland

Pa0009 012, Johnston

Pa0009 205, Brno

Pa0009 207, Olomouc

Pa0009 201, Prague

Pa0009 202, Prague

Pa0009 210, Prague

Pa0009 203, Zlín

Pa0009 302, Cologne

Pa0009 309, Erlangen

Pa0009 304, Hamburg

Pa0009 301, Ratingen

Pa0009 403, Budapest

Pa0009 401, Veszprém

Pa0009 452, Bialystok

Pa0009 453, Elblag

Pa0009 456, Elblag

Pa0009 455, Krakow

Pa0009 451, Poznan

Pa0009 450, Torun

Pa0009 454, Warsaw

Pa0009 459, Warsaw

Pa0009 465, Wroclaw

Pa0009 604, Moscow

Pa0009 605, Moscow

Pa0009 607, Moscow

Pa0009 606, Saint Petersburg

Pa0009 608, Saint Petersburg